Colgate-Palmolive Co. reported its fourth quarter 2024 earnings, with adjusted earnings per share (EPS) of $0.91, surpassing analyst estimates of $0.89. However, the company's revenue of $4.94 billion fell short of expectations set at $4.97 billion. The company anticipates flat net sales for the full year but projects organic sales growth of between 3% to 5% in 2025, slightly below the consensus estimate of 4.41%. Despite beating profit estimates, Colgate-Palmolive's stock experienced a decline following the announcement, attributed to the weaker-than-expected revenue and guidance. The company's global market share in toothpaste stands at 41.4% and in toothbrushes at 32.2%. Noel Wallace, Chairman, President, and CEO, highlighted the company's strong organic sales growth and improvements in various financial metrics for the year, including GAAP EPS of $0.90, Base Business EPS of $0.91, net income of $739 million, adjusted EBITDA of $1.21 billion, an operating margin of 21.5%, a free cash flow margin of 21.9%, organic revenue growth of 4.3%, and sales volume increase of 2.5%. The company's market capitalization stands at $74.26 billion, positioning it well for future growth.